Acute pancreatitis as an adverse side effect of L-asparaginase in the treatment of acute lymphoblastic leukemia
DOI:
https://doi.org/10.51481/amc.v60i2.1000Keywords:
acute lymphocytic leukemia, L-asparaginase, pancreatitisAbstract
The acute lymphocytic leukemia is the oncological disease with the highest incidence in the pediatric population both worldwide and in Costa Rica. It requires complex chemotherapy protocols, which confers a constant challenge on physicians to balance the risks and benefits of management. Therefore, it is necessary to take into account the risk factors of each patient, the degree of severity of the disease and the potential adverse effects of the treatment. A case report is presented with an acute non-biliary edematous pancreatitis, secondary to the use of L-asparaginase in a patient diagnosed with acute lymphocytic leukemia, seen at the National Children's Hospital ""Dr. Carlos Sáenz Herrera"". The patient who was started on the AHOPCA 2008 polychemotherapy regimen presented symptoms suggestive of acute pancreatitis on the day 50 of the same, so it was decided not to apply the indicated chemotherapy and transfer the patient to the Emergency Room. The clinical picture was associated with abnormal laboratories and ultrasound, so it was immediately treated interdisciplinarily, which is why its prognosis was favorable and currently he continues with chemotherapy treatment as indicated.
Downloads
References
M. Salud, Dirección Vigilancia de la Salud, Unidad de Seguimiento de Indicadores de Salud, Registro Nacional de Tumores. 6 páginas. Recuperado el 3 de septiembre, 2017. En: https://www.ministeriodesalud.go.cr/index.php/ vigilancia-de-la-salud/estadisticas-y-bases-de-datos/estadisticas/estadistica-decancer-registro-nacional-tumores/incidencia.
Ben Tanfous M, Sharif-Askari B, Ceppi F, Laaribi H, Gagne V, Rousseau J, et al. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia. Clin Cancer Res. 2015 Jan 15;21:329-334.
Navarrete M, Rossi E, Brivio E, Carrillo JM, Bonilla M, Vasquez R, et al. Epidemiology of childhood leukemia in Costa Rica. Treatment outcome DFWII Protocol. Pediatr Blood Cancer 2007;49:464 (abstr. PD 026).
Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et al. Toward the cure of all Children with cancer through collaborative efforts: pediatric oncology as a global challenge. J Clin Oncol. 2015 Sep 20;33:30653073.
Van den Berg, H. Leukemia & Lymphoma. Asparaginase revisited. Leuk Lymphoma. 2011 Feb;52:168-178.
Flores-Calderón J, Exiga-Gonzaléz E, Morán-Villota S, Martín-Trejo J, Yamamoto-Nagano A. Acute pancreatitis in children wjth acute lymphoblastic leukemia treated with L-Asparaginase. J Pediatr Hematol Oncol. 2009 Oct;31:790-793.
Nicklas Sundell N, Boström H, Edenholm M, Abrahamsson J. Management of neutropenic enterocolitis in children with cancer. Acta Paediatr. 2012 Mar;101:308-312.
Treepongkaruna S, Thongpak N, Pakakasama S, Pienvichit P, Sirachainan N, Hongeng S. Acute Pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J Pediatr Hematol Oncol. 2009 Nov;31:812-815.
Abajj R, Gagné V, Xu CJ, Spinella JF, Ceppi F, Laverdiére C, et al. Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patients. Oncotarget. 2017 Jul 4;8:43752-43767.
Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001 Mar 1;97:1211-1218.
Pession A, Valsecchi MG, Masera G, Kamps WA, Magyarosy E, Rizzari C, et al. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol. 2005 Oct 1;23:7161-7167.
Kearney SL, Dahlberg SE, Levy DE, Voss SD, Sallan SE, Silverman LB. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatr Blood Cancer. 2009 Aug;53:162167.
Wolthers BO, Frandsen TL, Baruchel A, Attarbaschi A, Barzilai S, Colombini A, et al. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. Lancet Oncol. 2017 Sep;18:1238-1248.
Sakaguchi S, Higa T, Suzuki M, Fujimura J, Shimizu T. Prophylactic use of octreotide for asparaginase-induced acute pancreatitis. Int J Hematol. 2017 Aug;106:266-268.
Wu SF, Chen AC, Peng CT, Wu KH. Octreotide Therapy in AsparaginaseAssociated Pancreatitis in Childhood Acute Lymphoblastic Leukemia. Pediatr Blood Cancer. 2008 Dec;51:824-825.
Downloads
Published
Versions
- 2018-05-03 (2)
- 2018-05-03 (1)
Issue
Section
License
Copyright (c) 2018 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
